F2 Bioscience I 2017 Ltd Cullinan Oncology, Inc. (CGEM) insider trading activity

CGEM Quotes by TradingView

F2 Bioscience I 2017 LTD is > 10% Shareholder of Cullinan Oncology, Inc.. Currently has a direct ownership of 537,392 shares of CGEM, which is worth approximately $6.59 Million. The most recent transaction as insider was on Jun 23, 2022, when has been sold 29,631 shares (Common Stock) at a price of $13.0 per share, resulting in proceeds of $385,203. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 537K
0% 3M change
0% 12M change
Total Value Held $6.59 Million

F2 Bioscience I 2017 Ltd Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 23 2022
SELL
Open market or private sale
$385,203 $13.0 p/Share
29,631 Reduced 5.23%
537,392 Common Stock
Jun 22 2022
SELL
Open market or private sale
$634,403 $12.7 p/Share
49,953 Reduced 8.1%
567,023 Common Stock
Jun 21 2022
SELL
Open market or private sale
$285,014 $12.77 p/Share
22,319 Reduced 3.49%
616,976 Common Stock
FBI

F2 Bioscience I 2017 LTD

> 10% Shareholder
Geneva, V8

Track Institutional and Insider Activities on CGEM

Follow Cullinan Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CGEM shares.

Notify only if

Insider Trading

Get notified when an Cullinan Oncology, Inc. insider buys or sells CGEM shares.

Notify only if

News

Receive news related to Cullinan Oncology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CGEM